Matches in Nanopublications for { ?s ?p "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP745924.RAd3G_fVKWMfxpuCBRcZGraHpCofvEN5gZ6VNtKKhYNCw130_assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745924.RAd3G_fVKWMfxpuCBRcZGraHpCofvEN5gZ6VNtKKhYNCw130_provenance.
- NP731124.RAzYVHs7OW32uw6sl40WtYgtKns-Pe1VL6_TNSsEJ1qZI130_assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731124.RAzYVHs7OW32uw6sl40WtYgtKns-Pe1VL6_TNSsEJ1qZI130_provenance.
- assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.
- NP994386.RAIID1XPyerWbbpLVy_gbyuEYbpi1itSrWZnqZvlSZlas130_assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994386.RAIID1XPyerWbbpLVy_gbyuEYbpi1itSrWZnqZvlSZlas130_provenance.